Combining rexinoids with psoralen-ultraviolet A sheds light on the management of mycosis fungoides

Affiliations

¹ Department of Dermatology and Wound Healing, Institute of Infection and Immunity, Cardiff University School of Medicine and University Hospital of Wales, Heath Park, Cardiff, UK.

Comment

Z Ahmed et al. Br J Dermatol. 2012 Sep.

. 2012 Sep;167(3):467.

doi: 10.1111/j.1365-2133.2012.11192.x.

¹ Department of Dermatology and Wound Healing, Institute of Infection and Immunity, Cardiff University School of Medicine and University Hospital of Wales, Heath Park, Cardiff, UK.

No abstract available

Comment on

Efficacy and safety of bexarotene combined with psoralen-ultraviolet A (PUVA) compared with PUVA treatment alone in stage IB-IIA mycosis fungoides: final results from the EORTC Cutaneous Lymphoma Task Force phase III randomized clinical trial (NCT00056056).
Whittaker S, Ortiz P, Dummer R, Ranki A, Hasan B, Meulemans B, Gellrich S, Knobler R, Stadler R, Karrasch M. Whittaker S, et al. Br J Dermatol. 2012 Sep;167(3):678-87. doi: 10.1111/j.1365-2133.2012.11156.x. Br J Dermatol. 2012. PMID: 22924950 Clinical Trial.